29856367 36320315 33358976 32486858 29053763 34853444 33262683 27228218 32028585 35141350 33630023 32773990 33847261 33815066 28478700 27003753 34349002 28255969 32305965 32414297 35694125 35911417 29580100 33621144 35233102 28937950 27642278 3575966 - Search Results

Year	Number of Results
2016	7
2017	7
2018	6
2019	5
2020	7
2021	9
2022	7
2023	0

1

Gene therapy and genome surgery in the retina.

DiCarlo JE, Mahajan VB, Tsang SH. DiCarlo JE, et al. J Clin Invest. 2018 Jun 1;128(6):2177-2188. doi: 10.1172/JCI120429. Epub 2018 Jun 1. J Clin Invest. 2018. PMID: 29856367 Free PMC article. Review.

2

Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities.

Lohia A, Sahel DK, Salman M, Singh V, Mariappan I, Mittal A, Chitkara D. Lohia A, et al. Asian J Pharm Sci. 2022 Mar;17(2):153-176. doi: 10.1016/j.ajps.2022.02.001. Epub 2022 Feb 13. Asian J Pharm Sci. 2022. PMID: 36320315 Free PMC article. Review.

3

Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model.

Sun D, Sun W, Gao SQ, Wei C, Naderi A, Schilb AL, Scheidt J, Lee S, Kern TS, Palczewski K, Lu ZR. Sun D, et al. J Control Release. 2021 Feb 10;330:329-340. doi: 10.1016/j.jconrel.2020.12.010. Epub 2020 Dec 21. J Control Release. 2021. PMID: 33358976 Free PMC article.

4

Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep.

Ross M, Obolensky A, Averbukh E, Ezra-Elia R, Yamin E, Honig H, Dvir H, Rosov A, Hauswirth WW, Gootwine E, Banin E, Ofri R. Ross M, et al. Hum Gene Ther. 2020 Jul;31(13-14):719-729. doi: 10.1089/hum.2020.023. Epub 2020 Jul 6. Hum Gene Ther. 2020. PMID: 32486858

5

Concepts and Strategies in Retinal Gene Therapy.

Aguirre GD. Aguirre GD. Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5399-5411. doi: 10.1167/iovs.17-22978. Invest Ophthalmol Vis Sci. 2017. PMID: 29053763 Free PMC article. No abstract available.

6

Outer retinal transduction by AAV2-7m8 following intravitreal injection in a sheep model of CNGA3 achromatopsia.

Ross M, Obolensky A, Averbukh E, Desrosiers M, Ezra-Elia R, Honig H, Yamin E, Rosov A, Dvir H, Gootwine E, Banin E, Dalkara D, Ofri R. Ross M, et al. Gene Ther. 2022 Nov;29(10-11):624-635. doi: 10.1038/s41434-021-00306-1. Epub 2021 Dec 2. Gene Ther. 2022. PMID: 34853444

7

Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances.

McClements ME, Staurenghi F, MacLaren RE, Cehajic-Kapetanovic J. McClements ME, et al. Front Neurosci. 2020 Nov 11;14:570909. doi: 10.3389/fnins.2020.570909. eCollection 2020. Front Neurosci. 2020. PMID: 33262683 Free PMC article. Review.

8

Effects of Subretinal Gene Transfer at Different Time Points in a Mouse Model of Retinal Degeneration.

Dai X, Zhang H, Han J, He Y, Zhang Y, Qi Y, Pang JJ. Dai X, et al. PLoS One. 2016 May 26;11(5):e0156542. doi: 10.1371/journal.pone.0156542. eCollection 2016. PLoS One. 2016. PMID: 27228218 Free PMC article.

9

AAV-Mediated Gene Delivery to 3D Retinal Organoids Derived from Human Induced Pluripotent Stem Cells.

Garita-Hernandez M, Routet F, Guibbal L, Khabou H, Toualbi L, Riancho L, Reichman S, Duebel J, Sahel JA, Goureau O, Dalkara D. Garita-Hernandez M, et al. Int J Mol Sci. 2020 Feb 3;21(3):994. doi: 10.3390/ijms21030994. Int J Mol Sci. 2020. PMID: 32028585 Free PMC article.

10

Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration.

She K, Su J, Wang Q, Liu Y, Zhong X, Jin X, Zhao Q, Xiao J, Li R, Deng H, Lu F, Yang Y, Wei Y. She K, et al. Mol Ther Methods Clin Dev. 2022 Jan 10;24:210-221. doi: 10.1016/j.omtm.2022.01.002. eCollection 2022 Mar 10. Mol Ther Methods Clin Dev. 2022. PMID: 35141350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results